166 related articles for article (PubMed ID: 32266955)
1. Quantitative and qualitative Ductus Venosus blood flow evaluation in the screening for Trisomy 18 and 13 - suitability study.
Czuba B; Nycz-Reska M; Cnota W; Jagielska A; Wloch A; Borowski D; Wegrzyn P
Ginekol Pol; 2020; 91(3):144-148. PubMed ID: 32266955
[TBL] [Abstract][Full Text] [Related]
2. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.
Ghaffari SR; Tahmasebpour AR; Jamal A; Hantoushzadeh S; Eslamian L; Marsoosi V; Fattahi F; Rajaei M; Niroomanesh S; Borna S; Beigi A; Khazardoost S; Saleh-Gargari S; Rahimi-Sharbaf F; Farrokhi B; Bayani N; Tehrani SE; Shahsavan K; Farzan S; Moossavi S; Ramezanzadeh F; Dastan J; Rafati M
Ultrasound Obstet Gynecol; 2012 May; 39(5):528-34. PubMed ID: 21793085
[TBL] [Abstract][Full Text] [Related]
3. A mixture model of ductus venosus pulsatility index in screening for aneuploidies at 11-13 weeks' gestation.
Maiz N; Wright D; Ferreira AF; Syngelaki A; Nicolaides KH
Fetal Diagn Ther; 2012; 31(4):221-9. PubMed ID: 22614037
[TBL] [Abstract][Full Text] [Related]
4. First-trimester screening for trisomies 21, 18 and 13 by ultrasound and biochemical testing.
Wright D; Syngelaki A; Bradbury I; Akolekar R; Nicolaides KH
Fetal Diagn Ther; 2014; 35(2):118-26. PubMed ID: 24356462
[TBL] [Abstract][Full Text] [Related]
5. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
6. First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing.
Kagan KO; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):42-7. PubMed ID: 25307357
[TBL] [Abstract][Full Text] [Related]
7. Nasal bone in screening for Trisomy 18 and 13 at 11-13 + 6 weeks of gestation - own experiences.
Czuba B; Maczka M; Cnota W; Wloch A; Jagielska A; Niesluchowska-Hoxha A; Borowski D
Ginekol Pol; 2020; 91(5):256-261. PubMed ID: 32495931
[TBL] [Abstract][Full Text] [Related]
8. Screening for trisomy 21 based on maternal age, nuchal translucency measurement, first trimester biochemistry and quantitative and qualitative assessment of the flow in the DV - the assessment of efficacy.
Czuba B; Zarotyński D; Dubiel M; Borowski D; Węgrzyn P; Cnota W; Reska-Nycz M; Mączka M; Wielgoś M; Sodowski K; Serafin D; Kubaty A; Bręborowicz GH
Ginekol Pol; 2017; 88(9):481-485. PubMed ID: 29057433
[TBL] [Abstract][Full Text] [Related]
9. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
Maiz N; Valencia C; Kagan KO; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 May; 33(5):512-7. PubMed ID: 19338027
[TBL] [Abstract][Full Text] [Related]
10. The role of ductus venosus Doppler flow in the diagnosis of chromosomal abnormalities during the first trimester of pregnancy.
Florjański J; Fuchs T; Zimmer M; Homola W; Pomorski M; Blok D
Adv Clin Exp Med; 2013; 22(3):395-401. PubMed ID: 23828681
[TBL] [Abstract][Full Text] [Related]
11. First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers.
Borrell A; Gonce A; Martinez JM; Borobio V; Fortuny A; Coll O; Cuckle H
Prenat Diagn; 2005 Oct; 25(10):901-5. PubMed ID: 16034840
[TBL] [Abstract][Full Text] [Related]
12. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
13. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing.
Nicolaides KH; Wright D; Poon LC; Syngelaki A; Gil MM
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):41-50. PubMed ID: 23744626
[TBL] [Abstract][Full Text] [Related]
14. Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomies 21, 18 and 13 and Turner syndrome.
Karadzov-Orlic N; Egic A; Milovanovic Z; Marinkovic M; Damnjanovic-Pazin B; Lukic R; Joksic I; Curkovic A; Mikovic Z
Prenat Diagn; 2012 Jul; 32(7):638-43. PubMed ID: 22570267
[TBL] [Abstract][Full Text] [Related]
15. Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing.
Kagan KO; Staboulidou I; Cruz J; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2010 Nov; 36(5):542-7. PubMed ID: 20503223
[TBL] [Abstract][Full Text] [Related]
16. Absence of an anatomical origin for altered ductus venosus flow velocity waveforms in first-trimester human fetuses with increased nuchal translucency.
Burger NB; Matias A; Kok E; de Groot CJ; Christoffels VM; Bekker MN; Haak MC
Prenat Diagn; 2016 Jun; 36(6):537-44. PubMed ID: 27060369
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
18. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
Nicolaides KH; Syngelaki A; Poon LC; Gil MM; Wright D
Fetal Diagn Ther; 2014; 35(3):185-92. PubMed ID: 24192489
[TBL] [Abstract][Full Text] [Related]
19. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
[TBL] [Abstract][Full Text] [Related]
20. Abnormal ductus venosus flow and tricuspid regurgitation at 11-14 weeks' gestation have high positive predictive values for increased risk in first-trimester combined screening test: results of a pilot study.
Ozkaya O; Sezik M; Ozbasar D; Kaya H
Taiwan J Obstet Gynecol; 2010 Jun; 49(2):145-50. PubMed ID: 20708518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
